Heat Shock Protein SDHAF2: Potential Drug Target Or Biomarker

Target Name: SDHAF2

NCBI ID: G54949

SDHAF2

Heat Shock Protein SDHAF2: Potential Drug Target Or Biomarker

SDHAF2 (hSDH5) is a heat shock protein (hSP70) that is expressed in various tissues and cells, including the brain, heart, and liver. It plays a crucial role in the regulation of heat shock stress responses in these cells, and is a potential drug target or biomarker for various diseases.

The hSP70 family of proteins is a subset of the SP70 family, which is characterized by the presence of a catalytic domain and a transmembrane region. SDHAF2 is a member of the hSP70 family and is expressed in a variety of tissues and cells, including the brain, heart, and liver. It is involved in a variety of cellular processes, including cell signaling, DNA replication, and stress response.

One of the key functions of SDHAF2 is its role in the regulation of heat shock stress responses. During times of stress, such as exposure to thermal or chemical stress, cells are able to detect and respond to these stimuli by activating a variety of stress pathways. These pathways involve the activation of various signaling pathways, including the stress-induced signaling pathway (SIS), which is a critical pathway that allows cells to detect and respond to stress signals.

In addition to its role in stress response, SDHAF2 is also involved in the regulation of cell signaling and metabolism. It has been shown to be involved in a variety of signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. These pathways are involved in a variety of cellular processes, including cell growth, apoptosis, and metabolism.

As a potential drug target or biomarker, SDHAF2 is of interest because of its involvement in a variety of cellular processes that are involved in various diseases. For example, it is involved in the regulation of stress responses, which is implicated in a variety of diseases, including heart disease, neurodegenerative diseases, and cancer. It is also involved in the regulation of cell signaling and metabolism, which is implicated in a variety of diseases, including diabetes, obesity, and cancer.

In addition to its potential as a drug target or biomarker, SDHAF2 is also of interest because of its expression pattern. It is expressed in a variety of tissues and cells, including the brain, heart, and liver, and has been shown to be involved in a variety of cellular processes. This makes it a potential target for drugs that can modulate its expression or activity.

In conclusion, SDHAF2 is a heat shock protein that is expressed in various tissues and cells. It plays a crucial role in the regulation of heat shock stress responses in these cells and is a potential drug target or biomarker for various diseases. Further research is needed to fully understand its functions and potential as a drug target or biomarker.

Protein Name: Succinate Dehydrogenase Complex Assembly Factor 2

Functions: Plays an essential role in the assembly of succinate dehydrogenase (SDH), an enzyme complex (also referred to as respiratory complex II) that is a component of both the tricarboxylic acid (TCA) cycle and the mitochondrial electron transport chain, and which couples the oxidation of succinate to fumarate with the reduction of ubiquinone (coenzyme Q) to ubiquinol. Required for flavinylation (covalent attachment of FAD) of the flavoprotein subunit SDHA of the SDH catalytic dimer

The "SDHAF2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SDHAF2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets